blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3137604

EP3137604 - COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.05.2021
Database last updated on 13.04.2024
FormerThe patent has been granted
Status updated on  12.06.2020
FormerGrant of patent is intended
Status updated on  15.12.2019
FormerExamination is in progress
Status updated on  16.03.2019
FormerRequest for examination was made
Status updated on  03.02.2017
FormerThe international publication has been made
Status updated on  25.11.2016
Most recent event   Tooltip23.06.2023Lapse of the patent in a contracting state
New state(s): CY		published on 26.07.2023  [2023/30]
Applicant(s)For all designated states
Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad, CA 92010 / US
[2017/10]
Inventor(s)01 / PRAKASH, Thazha, P.
2855 Gazelle Court
Carlsbad, CA 92010 / US
02 / SETH, Punit, P.
2855 Gazelle Court
Carlsbad, CA 92010 / US
03 / SWAYZE, Eric, E.
2855 Gazelle Court
Carlsbad, CA 92010 / US
04 / BHANOT, Sanjay
2855 Gazelle Court
Carlsbad, CA 92010 / US
05 / FREIER, Susan, M.
2855 Gazelle Court
Carlsbad, CA 92010 / US
06 / BUI, Huynh-Hoa
2855 Gazelle Court
Carlsbad, CA 92010 / US
 [2017/10]
Representative(s)Chapman, Desmond Mark
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2017/10]
Application number, filing date15786107.101.05.2015
[2017/10]
WO2015US28887
Priority number, dateUS201461987470P01.05.2014         Original published format: US 201461987470 P
US201462061071P07.10.2014         Original published format: US 201462061071 P
US201462082511P20.11.2014         Original published format: US 201462082511 P
[2017/10]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2015168618
Date:05.11.2015
Language:EN
[2015/44]
Type: A2 Application without search report 
No.:EP3137604
Date:08.03.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 05.11.2015 takes the place of the publication of the European patent application.
[2017/10]
Type: B1 Patent specification 
No.:EP3137604
Date:15.07.2020
Language:EN
[2020/29]
Search report(s)International search report - published on:US23.12.2015
(Supplementary) European search report - dispatched on:EP09.02.2018
ClassificationIPC:C12N15/113, C07H21/04, A61K31/712, A61K31/7125
[2017/49]
CPC:
C12N15/1138 (EP,IL,KR,RU,US); C12N15/11 (BR,RU); A61K31/7088 (KR,RU);
A61K47/549 (EP); A61K47/555 (KR,RU); A61K47/56 (EP);
A61P19/00 (EP,RU); A61P43/00 (EP); A61P5/06 (EP);
C07H21/04 (BR); C07K1/00 (BR); C12N5/00 (BR);
C12N2310/11 (EP,IL,KR,US); C12N2310/315 (EP,IL,KR,US); C12N2310/321 (IL,KR,US);
C12N2310/3231 (EP,IL,KR,US); C12N2310/3341 (EP,IL,KR,US); C12N2310/341 (EP,IL,KR,US);
C12N2310/346 (EP,IL,KR,US); C12N2310/351 (EP,IL,KR,US); C12N2310/3525 (IL) (-)
C-Set:
C12N2310/321, C12N2310/3525 (EP,US)
Former IPC [2017/10]C12N15/11, C07H21/04, C12N5/00, C07K1/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/10]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR MODULIERUNG DER WACHSTUMSHORMONREZEPTOREXPRESSION[2017/10]
English:COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION[2017/10]
French:COMPOSITIONS ET PROCÉDÉS POUR MODULER L'EXPRESSION DU RÉCEPTEUR DE L'HORMONE DE CROISSANCE[2017/10]
Entry into regional phase25.11.2016National basic fee paid 
25.11.2016Search fee paid 
25.11.2016Designation fee(s) paid 
25.11.2016Examination fee paid 
Examination procedure25.11.2016Examination requested  [2017/10]
25.11.2016Date on which the examining division has become responsible
10.09.2018Amendment by applicant (claims and/or description)
20.03.2019Despatch of a communication from the examining division (Time limit: M06)
27.09.2019Reply to a communication from the examining division
16.12.2019Communication of intention to grant the patent
27.04.2020Fee for grant paid
27.04.2020Fee for publishing/printing paid
27.04.2020Receipt of the translation of the claim(s)
Divisional application(s)EP20185802.4  / EP3757215
EP21196639.5  / EP3974534
Opposition(s)16.04.2021No opposition filed within time limit [2021/25]
Fees paidRenewal fee
10.05.2017Renewal fee patent year 03
11.05.2018Renewal fee patent year 04
15.05.2019Renewal fee patent year 05
31.03.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.05.2015
AL15.07.2020
CY15.07.2020
CZ15.07.2020
EE15.07.2020
HR15.07.2020
LT15.07.2020
LV15.07.2020
MC15.07.2020
PL15.07.2020
RO15.07.2020
RS15.07.2020
SI15.07.2020
SK15.07.2020
SM15.07.2020
BG15.10.2020
GR16.10.2020
IS15.11.2020
PT16.11.2020
[2023/30]
Former [2023/29]HU01.05.2015
AL15.07.2020
CZ15.07.2020
EE15.07.2020
HR15.07.2020
LT15.07.2020
LV15.07.2020
MC15.07.2020
PL15.07.2020
RO15.07.2020
RS15.07.2020
SI15.07.2020
SK15.07.2020
SM15.07.2020
BG15.10.2020
GR16.10.2020
IS15.11.2020
PT16.11.2020
Former [2022/07]AL15.07.2020
CZ15.07.2020
EE15.07.2020
HR15.07.2020
LT15.07.2020
LV15.07.2020
MC15.07.2020
PL15.07.2020
RO15.07.2020
RS15.07.2020
SI15.07.2020
SK15.07.2020
SM15.07.2020
BG15.10.2020
GR16.10.2020
IS15.11.2020
PT16.11.2020
Former [2021/36]AL15.07.2020
CZ15.07.2020
EE15.07.2020
HR15.07.2020
LT15.07.2020
LV15.07.2020
PL15.07.2020
RO15.07.2020
RS15.07.2020
SI15.07.2020
SK15.07.2020
SM15.07.2020
BG15.10.2020
GR16.10.2020
IS15.11.2020
PT16.11.2020
Former [2021/28]AL15.07.2020
CZ15.07.2020
EE15.07.2020
HR15.07.2020
LT15.07.2020
LV15.07.2020
PL15.07.2020
RO15.07.2020
RS15.07.2020
SK15.07.2020
SM15.07.2020
BG15.10.2020
GR16.10.2020
IS15.11.2020
PT16.11.2020
Former [2021/25]AL15.07.2020
CZ15.07.2020
EE15.07.2020
HR15.07.2020
LT15.07.2020
LV15.07.2020
PL15.07.2020
RO15.07.2020
RS15.07.2020
SM15.07.2020
BG15.10.2020
GR16.10.2020
IS15.11.2020
PT16.11.2020
Former [2021/22]CZ15.07.2020
EE15.07.2020
HR15.07.2020
LT15.07.2020
LV15.07.2020
PL15.07.2020
RO15.07.2020
RS15.07.2020
SM15.07.2020
BG15.10.2020
GR16.10.2020
IS15.11.2020
PT16.11.2020
Former [2021/10]HR15.07.2020
LT15.07.2020
LV15.07.2020
PL15.07.2020
RS15.07.2020
BG15.10.2020
GR16.10.2020
IS15.11.2020
PT16.11.2020
Former [2021/09]LT15.07.2020
BG15.10.2020
GR16.10.2020
PT16.11.2020
Former [2021/07]LT15.07.2020
Documents cited:Search[AD]WO2004078922  (ISIS PHARMACEUTICALS INC [US], et al) [AD] 1-15 * the whole document *;
 [AD]WO2013033230  (ISIS PHARMACEUTICALS INC [US], et al) [AD] 1-15 * the whole document *;
 [A]WO2013155204  (ALNYLAM PHARMACEUTICALS INC [US], et al) [A] 1-15 * the whole document *;
 [XP]WO2015002971  (ISIS PHARMACEUTICALS INC [US]) [XP] 1-5,7-9,11-15 * the whole document *;
 [E]WO2015179693  (ISIS PHARMACEUTICALS INC [US]) [E] 1-15 * page 155, paragraph 19. - page 156; table 20; sequence 91 ** claim - *;
 [E]WO2015188194  (ISIS PHARMACEUTICALS INC [US]) [E] 1-15 * page 162, paragraph 19.; table 20; sequence 91 * * example -; claim - *;
 [A]  - TACHAS G ET AL, "A GH receptor antisense oligonucleotide inhibits hepatic GH receptor expression, lGF-I production and body weight gain in normal mice", JOURNAL OF ENDOCRINOLOGY, (20060401), vol. 189, no. 1, doi:10.1677/JOE.1.06553, ISSN 0022-0795, pages 147 - 154, XP002442310 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1677/joe.1.06553
International search[Y]US2013053431  (TACHAS GEORGE [AU], et al) [Y] 1, 2, 19/(1, 2) * para [0099], [0203], Table 1 *;
 [Y]  - GenBank, (20110607), Database accession no. NM_000163.3, XP055245958 [Y] 1, 2, 19/(1, 2) * whole doc. *
by applicantUS4751219
 US4981957
 US5034506
 US5118800
 US5166315
 US5185444
 US5319080
 US5359044
 US5393878
 US5446137
 US5466786
 US5514785
 US5519134
 US5567811
 US5576427
 US5591722
 US5597909
 US5610300
 US5627053
 WO9720563
 US5639873
 US5646265
 US5670633
 WO9746098
 US5698685
 US5700920
 WO9813381
 US5792847
 WO9914226
 US5994517
 WO0149687
 US6268490
 US6300319
 US6383812
 WO0243771
 US6525191
 US6525031
 US2003077829
 US2003119724
 US6600032
 US6620916
 US6660720
 US6670461
 WO2004024757
 US6770748
 US2004171570
 WO2004078922
 US6794499
 WO2004101619
 WO2004106356
 WO2005021570
 US6906182
 US2005130923
 US6908903
 US2005164235
 WO2005121371
 US7034133
 WO2006047842
 US7053207
 US2006148740
 US2006178325
 US2006183886
 WO2007090071
 US7262177
 WO2007134181
 US2008039618
 US2008108801
 US7399845
 WO2008101157
 WO2008098788
 US2008206869
 US7427672
 US2008281044
 US2008281041
 WO2008150729
 WO2008154401
 WO2009006478
 US2009012281
 US7491805
 WO2009067647
 US7547684
 WO2009082607
 US7569686
 WO2009100320
 US2009203135
 US2009203132
 US7582744
 WO2009126933
 WO2009134487
 US2009286973
 WO2009143369
 WO2010036698
 WO2010036696
 US7696345
 WO2010054406
 US7723509
 WO2010077578
 WO2010088537
 US2010240730
 WO2010129709
 US7851615
 WO2010144740
 WO2010148013
 WO2011017521
 WO2011038356
 US2011097264
 US2011097265
 US2011123520
 WO2011100131
 US2011207799
 WO2011115818
 WO2011120053
 US2011269814
 WO2011163121
 US8106022
 US2012035115
 US8137695
 WO2012037254
 US8158601
 US2012095075
 US2012101148
 WO2012068187
 US2012128760
 US2012136042
 WO2012083185
 WO2012083046
 US2012157509
 US2012165393
 WO2012089352
 WO2012089602
 US2012230938
 US8313772
 WO2012177947
 US8344125
 US2013004427
 US8349308
 WO2013033230
 US8404862
 US2013109817
 US8435491
 US2013121954
 WO2013075035
 US8450467
 US2013178512
 US8501930
 US2013236968
 US8541548
 US8552163
 WO2013166121
 WO2013165816
    - TACHAS et al., J Endocrinol., (20060400), vol. 189, no. l, pages 147 - 54
    - MERWIN et al., Bioconjug Chem, (19940000), vol. 5, pages 612 - 620
    - GU et al., Nucleosides, Nucleotides & Nucleic Acids, (20050000), vol. 24, no. 5-7, pages 993 - 998
    - MAIER et al., "Synthesis of Antisense Oligonucleotides Conjugated to a Multivalent Carbohydrate Cluster for Cellular Targeting", Bioconjugate Chemistry, (20030000), vol. 14, doi:10.1021/bc020028v, pages 18 - 29, XP002510288

DOI:   http://dx.doi.org/10.1021/bc020028v
    - RENSEN et al., "Design and Synthesis of Novel N-Acetylgalactosamine-Terminated Glycolipids for Targeting of Lipoproteins to the Hepatic Asiaglycoprotein Receptor", J. Med. Chem., (20040000), vol. 47, doi:10.1021/jm049481d, pages 5798 - 5808, XP002551237

DOI:   http://dx.doi.org/10.1021/jm049481d
    - "Carbohydrate Modifications in Antisense Research", ACS Symposium Series, vol. 580, pages 40 - 65
    - "GENBANK", John Wiley & Sons, Inc, Database accession no. NW 001120958.1
    - WOOLF et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 7305 - 7309
    - GAUTSCHI et al., J. Natl. Cancer Inst., (20010300), vol. 93, pages 463 - 471
    - MAHERDOLNICK, Nuc. Acid. Res., (19880000), vol. 16, pages 3341 - 3358
    - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410
    - ZHANGMADDEN, Genome Res., (19970000), vol. 7, page 649 656
    - SMITHWATERMAN, Adv. Appl. Math., (19810000), vol. 2, page 482 489
    - ZHOU et al., J. Org. Chem., (20090000), vol. 74, pages 118 - 134
    - SINGH et al., Chem. Commun., (19980000), vol. 4, pages 455 - 456
    - KOSHKIN et al., Tetrahedron, (19980000), vol. 54, pages 3607 - 3630
    - WAHLESTEDT et al., Proc. Natl. Acad. Sci. U. S. A., (20000000), vol. 97, pages 5633 - 5638
    - KUMAR et al., Bioorg. Med. Chem. Lett., (19980000), vol. 8, pages 2219 - 2222
    - SINGH et al., J. Org. Chem., (19980000), vol. 63, pages 10035 - 10039
    - NAUWELAERTS et al., J. Am. Chem. Soc., (20070000), vol. 129, no. 30, pages 9340 - 9348
    - ELAYADI et al., Curr. Opinion Invest. Drugs, (20010000), vol. 2, pages 558 - 561
    - BRAASCH et al., Chem. Biol., (20010000), vol. 8, pages 1 - 7
    - ORUM et al., Curr. Opinion Mol. Ther., (20010000), vol. 3, pages 239 - 243
    - BAKER et al., J. Biol. Chem., (19970000), vol. 272, pages 11944 - 12000
    - MARTIN, Helv. Chim. Acta, (19950000), vol. 78, pages 486 - 504
    - ALTMANN et al., Chimia, (19960000), vol. 50, pages 168 - 176
    - ALTMANN et al., Biochem. Soc. Trans., (19960000), vol. 24, pages 630 - 637
    - ALTMANN et al., Nucleosides Nucleotides, (19970000), vol. 16, pages 917 - 926
    - LEUMANN, Bioorg. Med. Chem., (20020000), vol. 10, pages 841 - 854
    - BRAASCH et al., Biochemistry, (20020000), vol. 41, pages 4503 - 4510
    - ROBEYNS et al., J. Am. Chem. Soc., (20080000), vol. 130, no. 6, pages 1979 - 1984
    - HORVATH et al., Tetrahedron Letters, (20070000), vol. 48, pages 3621 - 3623
    - NAUWELAERTS et al., Nucleic Acids Research, (20050000), vol. 33, no. 8, pages 2452 - 2463
    - ROBEYNS et al., Acta Crystallographica, Section F: Structural Biology and Crystallization Communications, (20050000), vol. F61, no. 6, pages 585 - 586
    - GU et al., Tetrahedron, (20040000), vol. 60, no. 9, pages 2111 - 2123
    - GU et al., Oligonucleotides, (20030000), vol. 13, no. 6, pages 479 - 489
    - WANG et al., J. Org. Chem., (20030000), vol. 68, pages 4499 - 4505
    - VERBEURE et al., Nucleic Acids Research, (20010000), vol. 29, no. 24, pages 4941 - 4947
    - WANG et al., J. Org. Chem., (20010000), vol. 66, pages 8478 - 82
    - WANG et al., Nucleosides, Nucleotides & Nucleic Acids, (20010000), vol. 20, no. 4-7, pages 785 - 788
    - WANG et al., J. Am. Chem., (20000000), vol. 122, pages 8595 - 8602
    - Antisense Research and Applications, CRC Press, (19930000), pages 276 - 278
    - PARK et al., PNAS, (20050000), vol. 102, no. 47, pages 17125 - 17129
    - KHOREV et al., Bioorganic and Medicinal Chemistry, (20080500), vol. 16, no. 9, pages 5216 - 5231
    - BIESSEN et al., "The Cholesterol Derivative of a Triantennary Galactoside with High Affinity for the Hepatic Asialoglycoprotein Receptor: a Potent Cholesterol Lowering Agent", J. Med. Chem., (19950000), vol. 38, doi:10.1021/jm00011a003, pages 1846 - 1852, XP002552046

DOI:   http://dx.doi.org/10.1021/jm00011a003
    - BIESSEN et al., "Synthesis of Cluster Galactosides with High Affinity for the Hepatic Asialoglycoprotein Receptor", J. Med. Chem., (19950000), vol. 38, doi:10.1021/jm00009a014, pages 1538 - 1546, XP002552047

DOI:   http://dx.doi.org/10.1021/jm00009a014
    - LEE et al., "New and more efficient multivalent glyco-ligands for asialoglycoprotein receptor of mammalian hepatocytes", Bioorganic & Medicinal Chemistry, (20110000), vol. 19, doi:10.1016/j.bmc.2011.03.027, pages 2494 - 2500, XP055590519

DOI:   http://dx.doi.org/10.1016/j.bmc.2011.03.027
    - RENSEN et al., "Determination of the Upper Size Limit for Uptake and Processing of Ligands by the Asialoglycoprotein Receptor on Hepatocytes in Vitro and in Vivo", J. Biol. Chem., (20010000), vol. 276, no. 40, doi:10.1074/jbc.M101786200, pages 37577 - 37584, XP003010766

DOI:   http://dx.doi.org/10.1074/jbc.M101786200
    - RENSEN et al., "Design and Synthesis of Novel N-Acetylgalactosamine-Terminated Glycolipids for Targeting of Lipoproteins to the Hepatic Asialoglycoprotein Receptor", J. Med. Chem., (20040000), vol. 47, doi:10.1021/jm049481d, pages 5798 - 5808, XP002551237

DOI:   http://dx.doi.org/10.1021/jm049481d
    - SLIEDREGT et al., "Design and Synthesis of Novel Amphiphilic Dendritic Galactosides for Selective Targeting of Liposomes to the Hepatic Asialoglycoprotein Receptor", J. Med. Chem., (19990000), vol. 42, doi:10.1021/jm981078h, pages 609 - 618, XP002552045

DOI:   http://dx.doi.org/10.1021/jm981078h
    - VALENTIJN et al., "Solid-phase synthesis of lysine-based cluster galactosides with high affinity for the Asialoglycoprotein Receptor", Tetrahedron, (19970000), vol. 53, no. 2, doi:10.1016/S0040-4020(96)01018-6, pages 759 - 770, XP004105178

DOI:   http://dx.doi.org/10.1016/S0040-4020(96)01018-6
    - LEE, Carbohydr Res, (19780000), vol. 67, pages 509 - 514
    - CONNOLLY et al., J Biol Chem, (19820000), vol. 257, pages 939 - 945
    - PAVIA et al., Int J Pep Protein Res, (19830000), vol. 22, pages 539 - 548
    - LEE et al., Biochem, (19840000), vol. 23, pages 4255 - 4261
    - LEE et al., Glycoconjugate J, (19870000), vol. 4, pages 317 - 328
    - TOYOKUNI et al., Tetrahedron Lett, (19900000), vol. 31, pages 2673 - 2676
    - BIESSEN et al., J Med Chem, (19950000), vol. 38, pages 1846 - 1852
    - VALENTIJN et al., Tetrahedron, (19970000), vol. 53, pages 759 - 770
    - KIM et al., Tetrahedron Lett, (19970000), vol. 38, pages 3487 - 3490
    - RAJUR et al., Bioconjug Chem, (19970000), vol. 8, pages 935 - 940
    - KATO et al., Glycobiol, (20010000), vol. 11, pages 821 - 829
    - RENSEN et al., JBiol Chem, (20010000), vol. 276, pages 37577 - 37584
    - LEE et al., Methods Enzymol, (20030000), vol. 362, pages 38 - 43
    - WESTERLIND et al., Glycoconj J, (20040000), vol. 21, pages 227 - 241
    - LEE et al., Bioorg Med Chem Lett, (20060000), vol. 16, no. 19, pages 5132 - 5135
    - MAIERHOFER et al., Bioorg Med Chem, (20070000), vol. 15, pages 7661 - 7676
    - KHOREV et al., Bioorg Med Chem, (20080000), vol. 16, pages 5216 - 5231
    - LEE et al., Bioorg Med Chem, (20110000), vol. 19, pages 2494 - 2500
    - KORNILOVA et al., Analyt Biochem, (20120000), vol. 425, pages 43 - 46
    - PUJOL et al., Angew Chemie Int Ed Engl, (20120000), vol. 51, pages 7445 - 7448
    - SLIEDREGT et al., J Med Chem, (19990000), vol. 42, pages 609 - 618
    - RENSEN et al., J Med Chem, (20040000), vol. 47, pages 5798 - 5808
    - RENSEN et al., Arterioscler Thromb Vase Biol, (20060000), vol. 26, pages 169 - 175
    - VAN ROSSENBERG et al., Gene Ther, (20040000), vol. 11, pages 457 - 464
    - SATO et al., J Am Chern Soc, (20040000), vol. 126, pages 14013 - 14022
    - LEE et al., J Org Chem, (20120000), vol. 77, pages 7564 - 7571
    - BIESSEN et al., FASEB J, (20000000), vol. 14, pages 1784 - 1792
    - DUFF et al., Methods Enzymol, (20000000), vol. 313, pages 297 - 321
    - MAIER et al., Bioconjug Chem, (20030000), vol. 14, pages 18 - 29
    - JAYAPRAKASH et al., Org Lett, (20100000), vol. 12, pages 5410 - 5413
    - MANOHARAN, Antisense Nucleic Acid Drug Dev, (20020000), vol. 12, pages 103 - 128
    - TOMIYA et al., Bioorg Med Chem, (20130000), vol. 21, pages 5275 - 5281
    - SETH et al., Bioorg. Med. Chem., (20110000), vol. 21, no. 4, pages 1122 - 1125
    - J. Org. Chem., (20100000), vol. 75, no. 5, pages 1569 - 1581
    - Nucleic Acids Symposium Series, (20080000), vol. 52, no. 1, pages 553 - 554
    - WEBER et al., J. Med. Chem., (19910000), vol. 34, page 2692
    - RENSEN et al., J. Med. Chem., (20040000), vol. 47, pages 5798 - 5808
    - Analytical Biochemistry, (19950000), vol. 229, pages 54 - 60
    - J Lipid Res., (19910100), vol. 32, no. 1, pages 173 - 81
 US20080026995
 US20080097787
 WO1998DK00393
 WO2005US19219
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.